NCT03112655View on ClinicalTrials.gov

Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: Early Test-of-cure

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

February 24, 2017

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
African TrypanosomiasisAfrican; Trypanosomiasis, WestSleeping Sickness; West AfricanTrypanosoma Brucei Gambiense; Infection
Interventions
DIAGNOSTIC_TEST

RNA and neopterin detection

Detection of spliced leader RNA will be performed on blood and cerebrospinal fluid taken before treatment, 11 days after treatment, 6, 12 and 18 months after treatment. Neopterin and 5-hydroxytryptophan will be quantified in cerebrospinal fluid taken at the same time points.

Trial Locations (1)

Unknown

Programme Nationale de Lutte contre la trypanosomiase humaine Africaine, Kinshasa

All Listed Sponsors
collaborator

Institute of Tropical Medicine, Belgium

OTHER

collaborator

Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

OTHER

collaborator

Ministry of Public Health, Democratic Republic of the Congo

OTHER_GOV

lead

Institut de Recherche pour le Developpement

OTHER_GOV

NCT03112655 - Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: Early Test-of-cure | Biotech Hunter | Biotech Hunter